219 related articles for article (PubMed ID: 2976595)
1. Tay-Sachs disease: B1 variant.
Gordon BA; Gordon KE; Hinton GG; Cadera W; Feleki V; Bayleran J; Hechtman P
Pediatr Neurol; 1988; 4(1):54-7. PubMed ID: 2976595
[TBL] [Abstract][Full Text] [Related]
2. The Val192Leu mutation in the alpha-subunit of beta-hexosaminidase A is not associated with the B1-variant form of Tay-Sachs disease.
Hou Y; Vavougios G; Hinek A; Wu KK; Hechtman P; Kaplan F; Mahuran DJ
Am J Hum Genet; 1996 Jul; 59(1):52-8. PubMed ID: 8659543
[TBL] [Abstract][Full Text] [Related]
3. The mutation mechanism causing juvenile-onset Tay-Sachs disease among Lebanese.
Hechtman P; Boulay B; Bayleran J; Andermann E
Clin Genet; 1989 May; 35(5):364-75. PubMed ID: 2527097
[TBL] [Abstract][Full Text] [Related]
4. Introduction of the alpha subunit mutation associated with the B1 variant of Tay-Sachs disease into the beta subunit produces a beta-hexosaminidase B without catalytic activity.
Brown CA; Neote K; Leung A; Gravel RA; Mahuran DJ
J Biol Chem; 1989 Dec; 264(36):21705-10. PubMed ID: 2532211
[TBL] [Abstract][Full Text] [Related]
5. Ten novel mutations in the HEXA gene in non-Jewish Tay-Sachs patients.
Akli S; Chomel JC; Lacorte JM; Bachner L; Kahn A; Poenaru L
Hum Mol Genet; 1993 Jan; 2(1):61-7. PubMed ID: 8490625
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and molecular characterization of non-classic forms of Tay-Sachs disease in Brazil.
Rozenberg R; Kok F; Burin MG; Sá Miranda MC; Vasques C; Henriques-Souza AM; Giugliani R; Vainzof M; Pereira LV
J Child Neurol; 2006 Jun; 21(6):540-4. PubMed ID: 16948947
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and molecular aspects of late-onset GM2-gangliosidosis: B1 variant as a prototype.
Suzuki K; Vanier MT
Dev Neurosci; 1991; 13(4-5):288-94. PubMed ID: 1840099
[TBL] [Abstract][Full Text] [Related]
8. Late onset GM2 gangliosidosis: an alpha-locus genetic compound with near normal hexosaminidase activity.
Charrow J; Inui K; Wenger DA
Clin Genet; 1985 Jan; 27(1):78-84. PubMed ID: 3156697
[TBL] [Abstract][Full Text] [Related]
9. A shortened beta-hexosaminidase alpha-chain in an Italian patient with infantile Tay-Sachs disease.
Zokaeem G; Bayleran J; Kaplan P; Hechtman P; Neufeld EF
Am J Hum Genet; 1987 Jun; 40(6):537-47. PubMed ID: 2954459
[TBL] [Abstract][Full Text] [Related]
10. Beta-hexosaminidase: biosynthesis and processing of the normal enzyme, and identification of mutations causing Jewish Tay-Sachs disease.
Mahuran DJ
Clin Biochem; 1995 Apr; 28(2):101-6. PubMed ID: 7628066
[TBL] [Abstract][Full Text] [Related]
11. Normal transcription of the beta-hexosaminidase alpha-chain gene in the Ashkenazi Tay-Sachs mutation.
Paw BH; Neufeld EF
J Biol Chem; 1988 Feb; 263(6):3012-5. PubMed ID: 2449434
[TBL] [Abstract][Full Text] [Related]
12. Detection of Tay-Sachs disease carriers among individuals with thermolabile hexosaminidase B.
Peleg L; Goldman B
Eur J Clin Chem Clin Biochem; 1994 Feb; 32(2):65-9. PubMed ID: 8003579
[TBL] [Abstract][Full Text] [Related]
13. [Tay-Sachs disease].
Tanaka A
Nihon Rinsho; 1993 Sep; 51(9):2281-5. PubMed ID: 8411703
[TBL] [Abstract][Full Text] [Related]
14. Tay-Sachs disease with hexosaminidase A: characterization of the defective enzyme in two patients.
Bayleran J; Hechtman P; Kolodny E; Kaback M
Am J Hum Genet; 1987 Oct; 41(4):532-48. PubMed ID: 2959149
[TBL] [Abstract][Full Text] [Related]
15. Active arginine residues in beta-hexosaminidase. Identification through studies of the B1 variant of Tay-Sachs disease.
Brown CA; Mahuran DJ
J Biol Chem; 1991 Aug; 266(24):15855-62. PubMed ID: 1831451
[TBL] [Abstract][Full Text] [Related]
16. A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: implications for carrier screening.
Triggs-Raine BL; Mules EH; Kaback MM; Lim-Steele JS; Dowling CE; Akerman BR; Natowicz MR; Grebner EE; Navon R; Welch JP
Am J Hum Genet; 1992 Oct; 51(4):793-801. PubMed ID: 1384323
[TBL] [Abstract][Full Text] [Related]
17. Biochemistry and genetics of Tay-Sachs disease.
Gravel RA; Triggs-Raine BL; Mahuran DJ
Can J Neurol Sci; 1991 Aug; 18(3 Suppl):419-23. PubMed ID: 1834320
[TBL] [Abstract][Full Text] [Related]
18. A splicing defect due to an exon-intron junctional mutation results in abnormal beta-hexosaminidase alpha chain mRNAs in Ashkenazi Jewish patients with Tay-Sachs disease.
Ohno K; Suzuki K
Biochem Biophys Res Commun; 1988 May; 153(1):463-9. PubMed ID: 2837213
[TBL] [Abstract][Full Text] [Related]
19. Molecular forms of beta-N-acetylhexosaminidase in Epstein-Barr virus-transformed lymphoid cell lines from normal subjects and patients with Tay-Sachs disease.
Salvayre R; Maret A; Negre A; Lenoir G; Vuillaume M; Icart J; Didier J; Douste-Blazy L
Eur J Biochem; 1983 Jul; 133(3):627-33. PubMed ID: 6305653
[TBL] [Abstract][Full Text] [Related]
20. A new form of residual hexosaminidase activity in infantile Tay Sachs disease fibroblasts.
Hechtman P; Khoo K; Isaacs C
Clin Genet; 1983 Sep; 24(3):206-15. PubMed ID: 6226462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
